Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

Calley Means has built a following by railing against the U.S. health system, often hammering on alleged financial conflicts ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

Kennedy's rationale, laid out in a Wall Street Journal opinion piece, was based on a series of inaccuracies, calling the ACIP ...

CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...

PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with ...

Merck MRK boasts more than six blockbuster drugs in its portfolio, with the blockbuster PD-L1 inhibitor Keytruda being the ...

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are under review.

Calley Means has built a following within the “Make America Healthy Again” movement by railing against the failings of the ...

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...